<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the expression of apoptotic protein inhibitors, survivin and XIAP, in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and in the cell line MUTZ-1, as well as to explore the possible mechanisms of homoharringtonine (HHT) in the treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Bone marrow samples from 47 patients with de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> at diagnosis were examined and bone marrow samples from 15 <z:mpath ids='MPATH_458'>normal</z:mpath> donors were used as control </plain></SENT>
<SENT sid="2" pm="."><plain>A <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> cell line MUTZ-1 was used as in vitro model </plain></SENT>
<SENT sid="3" pm="."><plain>Detection of apoptotic cells and cell cycle analysis were performed with flow cytometry (FACS) </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of apoptotic protein inhibitor survivin and XIAP in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells were detected by RT-PCR technique </plain></SENT>
<SENT sid="5" pm="."><plain>MUTZ-1 were treated with antisense oligodeoxynucleotide (AS-ODNs) of survivin and or HHT, the effects were evaluated by cell viability and cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Survivin <z:chebi fb="2" ids="33699">mRNA</z:chebi> positive rate in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> were significantly higher than that in <z:mpath ids='MPATH_458'>normal</z:mpath> controls (38.3% and 0, respectively, P &lt; 0.01), and the positive rate in high risk group (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEBT</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) was significantly higher than that in RA/<z:mp ids='MP_0011356'>RAS</z:mp> group (53.6% and 16.7%, respectively, P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>XIAP was expressed in <z:hpo ids='HP_0000001'>all</z:hpo> untreated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and healthy controls </plain></SENT>
<SENT sid="8" pm="."><plain>XIAP <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in high risk group was significantly higher than that in RA/<z:mp ids='MP_0011356'>RAS</z:mp> subtypes and healthy controls (1.55 +/- 0.34, 0.74 +/- 0.24, and 1.01 +/- 0.28, respectively, P &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>However, XIAP <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was significantly lower in RA/<z:mp ids='MP_0011356'>RAS</z:mp> subtypes than in healthy control (0.74 +/- 0.24 and 1.01 +/- 0.28, P &lt; 0.054) </plain></SENT>
<SENT sid="10" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> peak detected by FACS analysis and positive Annexin V <z:chebi fb="0" ids="37926">FITC</z:chebi> staining on cell membrane indicated that HHT could induce MUTZ-1 cell undergoing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in dose- and time-dependent manners </plain></SENT>
<SENT sid="11" pm="."><plain>Treatment of MUTZ-1 cells with HHT revealed that HHT could significantly down-regulate survivinexpression but had no significant effect on XIAP expression in the cells </plain></SENT>
<SENT sid="12" pm="."><plain>AS-ODNs of survivin could inhibit MUTZ-1 cells growth, induce them to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and sensitize them to HHT </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: The expression levels of survivin; Institute of Hematology, <z:hpo ids='HP_0002664'>Oncology</z:hpo> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> Immunology, Robert Roessle Clinic, Humboldt University, Berlin, Germany (Wolf Dieter Ludwig, Christian Wuchter) and XIAP vary in different subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, suggesting that the proteins may play an important role in the pathogenesis of the disease </plain></SENT>
<SENT sid="14" pm="."><plain>Down-regulation of survivin in MUTZ-1 cells may be one of the mechanisms that HHT induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells </plain></SENT>
</text></document>